• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于深度学习的HER2-SISH乳腺组织病理学全切片图像中癌症区域评估方法

Deep-Learning-Based Approach in Cancer-Region Assessment from HER2-SISH Breast Histopathology Whole Slide Images.

作者信息

Rehman Zaka Ur, Ahmad Fauzi Mohammad Faizal, Wan Ahmad Wan Siti Halimatul Munirah, Abas Fazly Salleh, Cheah Phaik-Leng, Chiew Seow-Fan, Looi Lai-Meng

机构信息

Faculty of Engineering, Multimedia University, Cyberjaya 63100, Malaysia.

Institute for Research, Development and Innovation, IMU University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.

出版信息

Cancers (Basel). 2024 Nov 11;16(22):3794. doi: 10.3390/cancers16223794.

DOI:10.3390/cancers16223794
PMID:39594748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11593209/
Abstract

Fluorescence in situ hybridization (FISH) is widely regarded as the gold standard for evaluating human epidermal growth factor receptor 2 (HER2) status in breast cancer; however, it poses challenges such as the need for specialized training and issues related to signal degradation from dye quenching. Silver-enhanced in situ hybridization (SISH) serves as an automated alternative, employing permanent staining suitable for bright-field microscopy. Determining HER2 status involves distinguishing between "Amplified" and "Non-Amplified" regions by assessing HER2 and centromere 17 (CEN17) signals in SISH-stained slides. This study is the first to leverage deep learning for classifying Normal, Amplified, and Non-Amplified regions within HER2-SISH whole slide images (WSIs), which are notably more complex to analyze compared to hematoxylin and eosin (H&E)-stained slides. Our proposed approach consists of a two-stage process: first, we evaluate deep-learning models on annotated image regions, and then we apply the most effective model to WSIs for regional identification and localization. Subsequently, pseudo-color maps representing each class are overlaid, and the WSIs are reconstructed with these mapped regions. Using a private dataset of HER2-SISH breast cancer slides digitized at 40× magnification, we achieved a patch-level classification accuracy of 99.9% and a generalization accuracy of 78.8% by applying transfer learning with a Vision Transformer (ViT) model. The robustness of the model was further evaluated through k-fold cross-validation, yielding an average performance accuracy of 98%, with metrics reported alongside 95% confidence intervals to ensure statistical reliability. This method shows significant promise for clinical applications, particularly in assessing HER2 expression status in HER2-SISH histopathology images. It provides an automated solution that can aid pathologists in efficiently identifying HER2-amplified regions, thus enhancing diagnostic outcomes for breast cancer treatment.

摘要

荧光原位杂交(FISH)被广泛认为是评估乳腺癌中人表皮生长因子受体2(HER2)状态的金标准;然而,它也带来了一些挑战,比如需要专业培训以及与染料淬灭导致的信号降解相关的问题。银增强原位杂交(SISH)是一种自动化替代方法,采用适用于明场显微镜的永久染色。确定HER2状态需要通过评估SISH染色玻片上的HER2和17号染色体着丝粒(CEN17)信号来区分“扩增”和“非扩增”区域。本研究首次利用深度学习对HER2-SISH全玻片图像(WSIs)中的正常、扩增和非扩增区域进行分类,与苏木精和伊红(H&E)染色的玻片相比,HER2-SISH全玻片图像的分析要复杂得多。我们提出的方法包括两个阶段:首先,我们在带注释的图像区域上评估深度学习模型,然后将最有效的模型应用于全玻片图像以进行区域识别和定位。随后,叠加表示每个类别的伪彩色图,并用这些映射区域重建全玻片图像。使用一个以40倍放大率数字化的HER2-SISH乳腺癌玻片的私有数据集,通过应用视觉Transformer(ViT)模型进行迁移学习,我们实现了补丁级分类准确率为99.9%,泛化准确率为78.8%。通过k折交叉验证进一步评估了模型的稳健性,平均性能准确率为98%,同时报告了带有95%置信区间的指标以确保统计可靠性。该方法在临床应用中显示出巨大的前景,特别是在评估HER2-SISH组织病理学图像中的HER2表达状态方面。它提供了一种自动化解决方案,可以帮助病理学家有效地识别HER2扩增区域,从而提高乳腺癌治疗的诊断结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/22e4e4606e19/cancers-16-03794-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/af765d3114e9/cancers-16-03794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/c7243aeffbff/cancers-16-03794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/1160be79c1d1/cancers-16-03794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/ea8e6c29e140/cancers-16-03794-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/88773e8453c7/cancers-16-03794-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/af47dfde008c/cancers-16-03794-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/b6c0818cf20a/cancers-16-03794-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/a3f7d431015b/cancers-16-03794-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/a3dc53f57282/cancers-16-03794-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/46218752d150/cancers-16-03794-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/d3dfee9b076c/cancers-16-03794-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/bb13d1c4515c/cancers-16-03794-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/f92a8ac651ce/cancers-16-03794-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/502c0e496763/cancers-16-03794-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/22e4e4606e19/cancers-16-03794-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/af765d3114e9/cancers-16-03794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/c7243aeffbff/cancers-16-03794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/1160be79c1d1/cancers-16-03794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/ea8e6c29e140/cancers-16-03794-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/88773e8453c7/cancers-16-03794-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/af47dfde008c/cancers-16-03794-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/b6c0818cf20a/cancers-16-03794-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/a3f7d431015b/cancers-16-03794-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/a3dc53f57282/cancers-16-03794-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/46218752d150/cancers-16-03794-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/d3dfee9b076c/cancers-16-03794-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/bb13d1c4515c/cancers-16-03794-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/f92a8ac651ce/cancers-16-03794-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/502c0e496763/cancers-16-03794-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8959/11593209/22e4e4606e19/cancers-16-03794-g015.jpg

相似文献

1
Deep-Learning-Based Approach in Cancer-Region Assessment from HER2-SISH Breast Histopathology Whole Slide Images.基于深度学习的HER2-SISH乳腺组织病理学全切片图像中癌症区域评估方法
Cancers (Basel). 2024 Nov 11;16(22):3794. doi: 10.3390/cancers16223794.
2
Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.原位杂交法(ISH)检测乳腺癌 HER2 基因状态:与 FISH 的比较及观察者间可重复性评估。
Am J Surg Pathol. 2010 Jun;34(6):767-76. doi: 10.1097/PAS.0b013e3181d96231.
3
Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists.根据美国临床肿瘤学会和美国病理学家学会的指南,对自动银增强原位杂交(SISH)和荧光原位杂交(FISH)在乳腺癌HER2基因状态验证中的比较。
Virchows Arch. 2007 Jul;451(1):19-25. doi: 10.1007/s00428-007-0424-5. Epub 2007 Jun 12.
4
Computational approach for counting of SISH amplification signals for HER2 status assessment.用于HER2状态评估的SISH扩增信号计数的计算方法。
PeerJ Comput Sci. 2024 Oct 23;10:e2373. doi: 10.7717/peerj-cs.2373. eCollection 2024.
5
Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.使用组织微阵列对乳腺癌HER2基因扩增进行明场原位杂交:显色法(CISH)和自动银增强法(SISH)与患者预后的相关性
Diagn Mol Pathol. 2009 Jun;18(2):88-95. doi: 10.1097/PDM.0b013e31816f6374.
6
Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists.通过银原位杂交法描绘乳腺癌中HER2基因状态在各实验室和病理学家之间具有可重复性。
J Mol Diagn. 2008 Nov;10(6):527-36. doi: 10.2353/jmoldx.2008.080052. Epub 2008 Oct 2.
7
Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.使用改进的深度学习网络对全切片图像中的细胞膜进行自动分割,以评估 HER2 状态。
Comput Biol Med. 2019 Jul;110:164-174. doi: 10.1016/j.compbiomed.2019.05.020. Epub 2019 May 30.
8
Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer.双色银增强原位杂交检测乳腺癌 HER2 基因扩增。
Mod Pathol. 2011 Jun;24(6):794-800. doi: 10.1038/modpathol.2011.9. Epub 2011 Feb 11.
9
Review of In Situ Hybridization (ISH) Stain Images Using Computational Techniques.使用计算技术对原位杂交(ISH)染色图像进行综述。
Diagnostics (Basel). 2024 Sep 21;14(18):2089. doi: 10.3390/diagnostics14182089.
10
Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.评估自动银增强原位杂交(SISH)用于检测乳腺癌切除标本和粗针活检标本中HER2基因扩增的情况。
Histopathology. 2009 Jan;54(2):248-53. doi: 10.1111/j.1365-2559.2008.03185.x.